| Cathy D Vo, MD | |
|
601 Clara Barton Blvd, Suite 340, Garland, TX 75042-5738 | |
| (972) 272-5935 | |
| Not Available |
| Full Name | Cathy D Vo |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 15 Years |
| Location | 601 Clara Barton Blvd, Garland, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578791463 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | BP10035636 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| American Current Care Pa | 9739260019 | 429 |
News Archive
Studies released today explore the neurological component of dietary disorders, uncovering evidence that the brain's biological mechanisms may contribute to significant public health challenges - obesity, diabetes, binge eating, and the allure of the high-calorie meal. The findings were presented at Neuroscience 2012, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health.
ProMining Therapeutics, Ltd. today announced a new collaboration with Roche in the field of type 2 diabetes mellitus.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
The risk of developing psychosis is more than tripled for those who abuse cannabis, according to results from a new twin study.
› Verified 3 days ago
| Entity Name | American Current Care Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275651002 PECOS PAC ID: 9739260019 Enrollment ID: O20080131000349 |
News Archive
Studies released today explore the neurological component of dietary disorders, uncovering evidence that the brain's biological mechanisms may contribute to significant public health challenges - obesity, diabetes, binge eating, and the allure of the high-calorie meal. The findings were presented at Neuroscience 2012, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health.
ProMining Therapeutics, Ltd. today announced a new collaboration with Roche in the field of type 2 diabetes mellitus.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
The risk of developing psychosis is more than tripled for those who abuse cannabis, according to results from a new twin study.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cathy D Vo, MD 13465 Inwood Rd, #1402, Farmers Branch, TX 75244-5321 Ph: (281) 683-7812 | Cathy D Vo, MD 601 Clara Barton Blvd, Suite 340, Garland, TX 75042-5738 Ph: (972) 272-5935 |
News Archive
Studies released today explore the neurological component of dietary disorders, uncovering evidence that the brain's biological mechanisms may contribute to significant public health challenges - obesity, diabetes, binge eating, and the allure of the high-calorie meal. The findings were presented at Neuroscience 2012, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health.
ProMining Therapeutics, Ltd. today announced a new collaboration with Roche in the field of type 2 diabetes mellitus.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
The risk of developing psychosis is more than tripled for those who abuse cannabis, according to results from a new twin study.
› Verified 3 days ago
Dr. Stella Suk-yee Kwong, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2825 Belt Line Rd, Suite 103, Garland, TX 75044 Phone: 972-530-5550 Fax: 972-530-3632 | |
Dr. Eric D Beshires, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5345 N President George Bush Hwy, Garland, TX 75040 Phone: 972-495-5888 Fax: 972-495-0588 | |
Dr. John Volk, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7145 N President George Bush Hwy, Garland, TX 75044 Phone: 972-530-1900 Fax: 972-530-7400 | |
Sherri Lynn Morgan, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 601 Clara Barton Blvd, Suite 340, Garland, TX 75042 Phone: 469-800-2260 Fax: 469-800-2270 | |
Lauren Elizabeth Carlson, PA-C Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4402 Broadway Blvd Ste 1, Garland, TX 75043 Phone: 972-240-1789 | |
Walter Duane Hinshaw, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2201 Forest Ln, Garland, TX 75042 Phone: 972-276-6822 Fax: 972-487-4060 | |
Sadaf Saleem, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1805 W. Campbell Rd, Suite 101, Garland, TX 75044 Phone: 906-360-4755 Fax: 877-311-0460 |